Hyperbaric oxygen as an adjuvant to temozolomide nanoparticle inhibits glioma growth by inducing G2/M phase arrest
Author:
Affiliation:
1. College of Life Science & Technology, National Engineering Research Center for Nanomedicine, Huazhong University of Science & Technology, Wuhan, 430074, PR China
Abstract
Publisher
Future Medicine Ltd
Subject
Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering
Link
https://www.futuremedicine.com/doi/pdf/10.2217/nnm-2017-0395
Reference40 articles.
1. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end?
2. Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro
3. Glioma-targeting micelles for optical/magnetic resonance dual-mode imaging
4. Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules
5. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Hyperbaric Oxygen‐Facilitated Cancer Treatment: A Minireview;Advanced NanoBiomed Research;2024-03-10
2. Hyperbaric oxygen therapy—a new hope for Alzheimer’s patients: a case report and literature review;Exploration of Neuroprotective Therapy;2023-12-22
3. Harnessing Nuclear Energy to Gold Nanoparticles for the Concurrent Chemoradiotherapy of Glioblastoma;Nanomaterials;2023-10-24
4. Temozolomide: a cytostatic drug that is still important today;Acta Poloniae Pharmaceutica - Drug Research;2023-03-03
5. Temozolomide hexadecyl ester targeted plga nanoparticles for drug-resistant glioblastoma therapy via intranasal administration;Frontiers in Pharmacology;2022-08-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3